Skip to content
Home
Catuvab®
R&D
Technology
About Us
Business Development
Contact
Imprint
Privacy Policy
Technology
CATUVAB®
R&D
About Us
Business Development
News
Technology
CATUVAB®
R&D
About Us
Business Development
News
Contact Us
Blog
Latest news
New Multicenter Study Confirms: CATUVAB® Safely Removes Tumor Cells from Salvaged Blood
2 weeks ago
Read more
Successful Financing
9 months ago
Read more
Positive Top Line Results
1 year ago
Read more
Top Line Results presentation at NATA24
1 year ago
Read more
Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study
2 years ago
Read more
Lindis Blood Care Establishes Scientific Advisory Board of Leading Industry Experts
3 years ago
Read more
Lindis Blood Care successfully closes follow-on financing round
4 years ago
Read more
Lindis Blood Care Announces Publication of Clinical Pilot Study Results
4 years ago
Read more
Tumorzellfreies Eigenblut bei Krebsoperationen
4 years ago
Read more
Lindis’ Catuvab is designed to remove tumor cells from surgical blood
4 years ago
Read more
Lindis Initiates Clinical EU Certification Study REMOVE with CATUVAB®
4 years ago
Read more
Over 5 million euros for Lindis Blood Care
6 years ago
Read more
